Article

An epidemic of hypertensive disorders of pregnancy
- Author:
- Robert L. Barbieri, MD
The CDC recently reported that in 2019 hypertensive disorders of pregnancy (HDPs) were diagnosed in 15.9% of hospital deliveries. Does the...
Article

Mifepristone for the treatment of miscarriage and fetal demise
- Author:
- Robert L. Barbieri, MD
Mifepristone is an important agent for the treatment of miscarriage and fetal demise, improving successful resolution of the pregnancy loss....
Article
Misoprostol: Clinical pharmacology in obstetrics and gynecology
- Author:
- Robert L. Barbieri, MD
The effect of misoprostol on uterine contraction is greatly influenced by the dose and route of administration
Oxytocin and...
Article

Defending access to reproductive health care
- Author:
- Robert L. Barbieri, MD
- Barbara Levy, MD
- Andrew M. Kaunitz, MD
- David G. Mutch, MD
- James Simon, MD
- Amy Garcia, MD
- Cheryl Iglesia, MD
- Errol Norwitz, MD, PhD, MBA
- Jaimey Pauli, MD
- David Jaspan, DO
- Iris Krishna, MD, MPH
- Mark Trolice, MD
- Lubna Pal, MBBS, MS
- Jan Leslie Shifren, MD
- Sarah Prager, MD, MS
- Charles Miller, MD
- Eve Espey, MD, MPH
- Constance Bohon, MD
- Melissa Kottke, MD, MPH, MBA
- Sinha Sangeeta, MD
- Patrick Woodman, DO
If precedents set in Roe v Wade are overturned, ObGyns have several immediate and long-term challenges
...Article

Optimize detection and treatment of iron deficiency in pregnancy
- Author:
- Nawal Nour, MD, MPH
- Robert L. Barbieri, MD
We are in the midst of a nationwide severe blood product shortage, necessitating that we optimize maternal red blood cell status...
Article

How common is IUD perforation, expulsion, and malposition?
- Author:
- Robert L. Barbieri, MD
IUD perforation of the uterus is uncommon, occurring in 0.1% of low-risk patients. IUD expulsion is common, with a rate of...
Article

Will NAAT replace microscopy for the identification of organisms causing vaginitis?
- Author:
- Robert L. Barbieri, MD
Molecular testing is more sensitive and specific than microscopy for the identification of organisms causing disease. There will...
Article
Drospirenone vs norethindrone progestin-only pills. Is there a clear winner?
- Author:
- Robert L. Barbieri, MD
Among progestin-only contraceptive pills, compared to norethindrone, drospirenone has superior performance on key dimensions
...Article

Individualize the duration of postpartum magnesium treatment for patients with preeclampsia to best balance the benefits and harms of treatment
- Author:
- Robert L. Barbieri, MD
Magnesium treatment reduces the risk of seizure in patients with preeclampsia. However, prolonged postpartum magnesium infusion may cause harm,...
Article

Reduce the use of perioperative opioids with a multimodal pain management strategy
- Author:
- Michaela Farber, MD, MS
- Daniela Carusi, MD, MSc
- Robert L. Barbieri, MD
Patients undergoing cesarean surgery who were previously naïve to opioid medications have a 0.33% to 2.2% probability of transitioning to the...
Article

How to screen for prediabetes and type 2 diabetes in an ObGyn practice
- Author:
- Robert L. Barbieri, MD
In the United States, 1 in 7 adults has type 2 diabetes mellitus (T2DM), and one-quarter of people with T2DM are undiagnosed. Screening for...
Article

Can we return to the ABCs of crafting a medical record note?
- Author:
- Robert L. Barbieri, MD
Medical record “note bloat” is adversely impacting communication among clinicians. It is time to refocus on the ABCs of note writing including...
Article

Relugolix combination therapy: A novel hormonal treatment for AUB associated with uterine fibroids
- Author:
- Robert L. Barbieri, MD
Oral relugolix combination therapy (relugolix, estradiol, norethindrone acetate) was effective in controlling excess bleeding caused by uterine...
Article
Colorectal cancer screening, 2021: An update
- Author:
- Robert L. Barbieri, MD
The American Cancer Society now recommends screening for colorectal cancer starting at age 45 years, not 50. The best colorectal...
Article

3 cases of hormone therapy optimized to match the patient problem
- Author:
- Robert L. Barbieri, MD
There are 5 different dose combinations of ethinyl estradiol and norethindrone acetate, ranging from 2.5 µg to 30 µg of ethinyl estradiol, and a...